Diversified Trust Co Acquires New Position in Heartflow, Inc. $HTFL

Diversified Trust Co acquired a new position in shares of Heartflow, Inc. (NASDAQ:HTFL) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 14,200 shares of the company’s stock, valued at approximately $345,000.

A number of other hedge funds have also recently added to or reduced their stakes in HTFL. Caitong International Asset Management Co. Ltd bought a new stake in Heartflow in the fourth quarter worth approximately $27,000. Russell Investments Group Ltd. acquired a new stake in shares of Heartflow in the 4th quarter valued at $45,000. Legal & General Group Plc bought a new stake in Heartflow in the third quarter worth $59,000. Strs Ohio acquired a new position in Heartflow during the fourth quarter worth $99,000. Finally, Police & Firemen s Retirement System of New Jersey acquired a new stake in shares of Heartflow in the fourth quarter worth about $131,000.

Insider Transactions at Heartflow

In other news, insider Campbell Rogers sold 64,533 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $24.64, for a total value of $1,590,093.12. Following the transaction, the insider directly owned 81,002 shares of the company’s stock, valued at $1,995,889.28. The trade was a 44.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the firm’s stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $29.23, for a total value of $27,732,167.11. Following the sale, the insider directly owned 8,448,158 shares of the company’s stock, valued at $246,939,658.34. This represents a 10.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,180,338 shares of company stock valued at $64,012,598 in the last three months. 7.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently commented on HTFL shares. JPMorgan Chase & Co. lowered their price objective on Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a report on Thursday, March 19th. Canaccord Genuity Group decreased their target price on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. Weiss Ratings upgraded Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, June 12th. Wells Fargo & Company boosted their price objective on shares of Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. Finally, Piper Sandler reiterated an “overweight” rating on shares of Heartflow in a research note on Thursday, June 11th. Six analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $37.00.

Heartflow Stock Performance

HTFL opened at $35.68 on Friday. The firm has a market cap of $3.08 billion and a price-to-earnings ratio of -11.47. The firm’s 50-day simple moving average is $30.69 and its 200-day simple moving average is $28.60. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $41.22.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.08. The firm had revenue of $52.59 million for the quarter. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.